PRMB CEO Eric Foss Leads $2M Cluster Buy in Primo Brands

SEC Form 4 filing details showing Eric Foss's insider stock purchase at Primo Brands Corp

Primo Brands Corp (NYSE: PRMB) saw a notable show of insider confidence on August 10, 2026, when Executive Chairman and CEO Eric J. Foss purchased 83,900 shares on the open market at $23.80 per share, a transaction valued at $1,996,543.13. The buy was made with Foss’s own capital rather than through an option exercise or … Read more

COE CEO Huang Buys $3.94M More, Spree Hits $21.5M

Stock chart and SEC filing document representing insider stock purchases by 51Talk Online Education Group CEO

Huang Jack Jiajia, the Chief Executive Officer, a director, and a 10%+ owner of 51Talk Online Education Group (COE), disclosed another open-market purchase of company stock in a Form 4 filing. On August 10, 2026, Huang bought 199,980 shares at $19.72 apiece, a purchase worth $3,943,605.60. Following the transaction, Huang’s indirect holdings — reported as … Read more

RSG: Cascade Investment Buys $108M in Republic Services Stock

Chart showing Republic Services (RSG) stock alongside a series of insider purchase transactions by Cascade Investment

A fresh Form 4 filing shows Cascade Investment, L.L.C., a 10%+ owner of Republic Services, Inc. (NYSE: RSG), purchased 3,200 shares of the waste-management giant on August 11, 2026, at $214.67 per share. The single transaction was worth $686,951.36 and lifted Cascade’s directly held stake to 111,068,846 shares. That trade, however, is just one piece … Read more

BLSM Director Carl Gordon Buys $10M in Open-Market Purchase

SEC Form 4 filing document showing an insider stock purchase disclosure for BlossomHill Therapeutics

A fresh Form 4 filing shows Carl L. Gordon, a director of BlossomHill Therapeutics, Inc. (BLSM), purchased 625,000 shares of the company on the open market on August 10, 2026. The transaction, priced at $16.00 per share, totaled $10,000,000.00 — a purchase made with the insider’s own funds rather than acquired through options or other … Read more

BLSM Insider Buy: OrbiMed Advisors Spends $10M on Shares

Illustration of an SEC Form 4 filing document showing an insider stock purchase by OrbiMed Advisors LLC in BlossomHill Therapeutics

A director of BlossomHill Therapeutics, Inc. (BLSM) put real money on the table this week. According to a Form 4 filing, OrbiMed Advisors LLC purchased 625,000 shares of BlossomHill on August 10, 2026, in an open-market transaction priced at $16.00 per share. The total outlay came to an even $10,000,000.00, funded directly by the insider … Read more

GLIBK: Malone Adds $1.7M in Cluster Buy Topping $13.5M

SEC Form 4 filing showing John C. Malone's insider stock purchase in Liberty Capital Corp/NV (GLIBK)

Liberty Capital Corp/NV (GLIBK) disclosed another insider purchase this week, with director and 10%+ owner John C. Malone buying 66,702 shares on August 12, 2026 at $25.57 per share, a purchase worth $1,705,623.50. Following the transaction, Malone’s directly held stake stands at 2,558,752 shares. The filing is notable less for its standalone size than for … Read more

BRVE Insider Erez Chimovits Buys $30M in Cluster Deal

Stock chart and SEC Form 4 filing document for Braveheart Bio (BRVE) insider stock purchase

A new Form 4 filing shows Erez Chimovits, a Director and 10%+ Owner of Braveheart Bio, Inc. (BRVE), purchased 1,666,667 shares on the open market on 2026-08-07 at $18.00 per share, a total outlay of $30,000,006.00. Following the purchase, Chimovits holds 11,901,826 shares indirectly, through a trust or entity structure rather than in a personal … Read more

OrbiMed Buys $30M of Braveheart Bio (BRVE) Stock

SEC Form 4 filing details showing OrbiMed Advisors LLC's purchase of Braveheart Bio (BRVE) shares

OrbiMed Advisors LLC, a director and 10%-plus owner of Braveheart Bio, Inc. (BRVE), disclosed an open-market purchase of 1,666,667 shares at $18.00 apiece, a cash outlay of $30,000,006.00, according to a Form 4 filed with the SEC. The transaction is dated August 7, 2026, and brings OrbiMed’s indirectly held stake to 11,901,826 shares. The purchase … Read more

TXO Partners: Simpson Buys $1.4M, Part of $3.5M Cluster

Chart showing three insider stock purchases by Bob R. Simpson at TXO Partners between August 7 and August 11, 2026

TXO Partners, L.P. (TXO) insider Bob R. Simpson disclosed an open-market purchase of 100,000 shares on August 11, 2026, paying $14.27 per share for a total outlay of $1,427,480. Following the trade, Simpson’s directly held stake stands at 9,350,000 shares, according to the Form 4 filed with the SEC. The purchase was made with Simpson’s … Read more

Bankers Life Buys $5M Stake in Privacore VPC Credit Fund

SEC Form 4 filing document showing Bankers Life & Casualty Co.'s stock purchase details

A newly filed Form 4 with the Securities and Exchange Commission shows that Bankers Life & Casualty Co., acting in its capacity as a 10%+ owner, purchased a substantial block of shares in Privacore VPC Asset Backed Credit Fund on August 7, 2026. The filing shows no ticker symbol associated with the fund, consistent with … Read more

GoldenTree’s $10M QVCG Buying Spree Continues

SEC Form 4 filing document showing GoldenTree Asset Management's insider purchase of QVC Group shares

QVC Group, Inc. (QVCG) disclosed another insider purchase this week, part of a broader pattern of buying by one of its largest shareholders. According to a Form 4 filed with the SEC, GoldenTree Asset Management LP, listed as a 10%+ owner of the company, purchased 308 shares of QVCG on the open market on August … Read more

Aptiv CEO Kevin Clark Buys $2.5M in APTV Shares

Aptiv PLC logo with a stock chart representing an insider stock purchase by CEO Kevin Clark

Aptiv PLC (APTV) Chair and CEO Kevin P. Clark disclosed an open-market purchase of 51,190 shares on August 10, 2026, according to a Form 4 filing with the SEC. The shares were bought at $48.89 apiece, for a total outlay of $2,502,684.22. Following the transaction, Clark holds 651,016 shares directly, a stake that reflects a … Read more